Korean vendor Medison is known primarily for its work in ultrasound,so its debut of a new whole-body MRI scanner at the Chicago meetingshould cause a few heads to turn. Medison will display Magnum,an investigational 1-tesla scanner making its U.S.
Korean vendor Medison is known primarily for its work in ultrasound,so its debut of a new whole-body MRI scanner at the Chicago meetingshould cause a few heads to turn. Medison will display Magnum,an investigational 1-tesla scanner making its U.S. conferencedebut. The work-in-progress system was developed over the pastyear as a collaboration between Medison engineers in Korea andstaff employed by Medison subsidiary Atlanta MR in Atlanta.
The company installed the second Magnum system last month inKorea and is planning to apply for regulatory clearance in theU.S., according to Prem Anand, Atlanta MR president. The companyis considering possible distribution of Magnum in Latin Americathrough its ultrasound equipment sales force. Atlanta MR is alsodeveloping a 3-tesla whole body scanner for research spectroscopy,Anand said.
Anand joined Atlanta MR in January, shortly after Medison establishedits U.S. MR operation. He is a veteran of Atlanta-based imagingservices firm Health Images, where he was executive vice presidentin charge of engineering, manufacturing, and product development.
In Medison's more traditional ultrasound business, the companywill display Combison 530, the 3-D ultrasound scanner it acquiredwith its purchase of Austrian firm Kretztechnik in April (SCAN5/22/96). Combison 530 is awaiting 510(k) clearance, which Medisonhopes will be forthcoming by the end of this year, according toMark Hayward, president of Medison's U.S. subsidiary in Pleasanton,CA.
Medison will also debut SonoAce 7700, the company's first color-flowscanner. The system is being sold in international markets buthas just entered the FDA's review process, Hayward said.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.